J.P. Turner & Co Capital Management’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

J.P. Turner & Co Capital Management’s Portfolio ONCT Stock Details ONCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$17K	Hold	15	–	–	0.02%	179
2015 Q2	$32K	Hold	15	–	–	0.02%	216
2015 Q1	$14K	Hold	15	–	–	0.01%	205
2014 Q4	$15K	Buy	+15	New	+$13.4K	0.01%	198

Other funds holding ONCT

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

FHA

First Horizon Advisors Memphis, Tennessee $3.85B AUM 16.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SIM

Spark Investment Management New York $51.2M AUM 87.14% 1-Year Est. Return

J.P. Turner & Co Capital Management's ONCT Position: Q3 2015 in Review

J.P. Turner & Co Capital Management held its Oncternal Therapeutics, Inc. Common Stock (ONCT) position steady in Q3 2015 at 15 shares worth $17K. The position accounts for 0.02% of the portfolio, ranked #179.

J.P. Turner & Co Capital Management first reported a position in ONCT in Q4 2014 and has held it in 4 quarters since. The position peaked at $32K in Q2 2015. 38 funds tracked by Wall St. Rank hold ONCT as of Q3 2015.

J.P. Turner & Co Capital Management held 15 shares of Oncternal Therapeutics, Inc. Common Stock worth $17K as of Q3 2015.
J.P. Turner & Co Capital Management left its Oncternal Therapeutics, Inc. Common Stock share count unchanged in Q3 2015.
Oncternal Therapeutics, Inc. Common Stock made up 0.02% of J.P. Turner & Co Capital Management's portfolio in Q3 2015, its #179 holding.
J.P. Turner & Co Capital Management first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q4 2014 and has held it in 4 quarters since.
J.P. Turner & Co Capital Management's Oncternal Therapeutics, Inc. Common Stock position peaked at $32K in Q2 2015.
38 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q3 2015.

Based on J.P. Turner & Co Capital Management's 13F filing for Q3 2015, filed 4 Nov 2015.